Abbott Healthcare faces 5 year ban from Tamil Nadu Govt agency: Report
Chennai: Coming down heavily on Abbott Healthcare, the Tamil Nadu Medical Services Corporation (TNMSC) has placed the company on 5-year ban list for allegedly concealing the fact that it has been banned by Directorate General of Health Services (DGHS) and Employees' State Insurance Corporation (ESIC), according to a recent media report in Times of India.
This is not the first time that the American healthcare and medical device giant has come under flak. Prior to this, Abbott was condemned by the United States Food and Drug Administration (USFDA) after a fatal bacteria, cronobacter, was found at its baby formula-making plant in February.
On April 24, 2018, the DGHS's Medical Stores Organisation had first blacklisted the company for 5 years for supply of Stromix, a blood thinner, and Becozyme C Forte on "quality" grounds, while, in October 2021, ESIC, New Delhi blacklisted it for hiding that it was on DGHS blacklist.
As per TNMSC managing director Deepak Jacob, Abbott has now once again landed in trouble after allegedly repeating the same mistake in Tamil Nadu.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.